Proteome Sciences Plc

Proteome Sciences (PRM)

Buy
Sell
Company name:Proteome Sciences Plc
EPIC:PRMTrading Currency:GBX
Market Sector:ASM8ISIN:GB0003104196
Market Segment:AMSMShare Type:DE
WWW Address:http://www.proteome.co.uk/Description:ORD 1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 3.90 images.advfn.com/imagesnew/2/gb/down -0.6 [-13.33] 3.60 4.20 4.22 4.22 4.22 546,633
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 11.49 294.65 -0.01 0.05 - 78.00 - 7.00 - 2.35

Proteome Sciences Key Figures

(at previous day's close)
Market Cap.11.49m
Shares In Issue294.65m
Prev. Close4.50
PE Ratio78.00 
Dividend Yield-%
EPS - basic0.05p
Dividend PS-p
Dividend Cover- 
Cash Flow PS0.01p
Return On Equity (ROE)-%
Operating Margin-0.77%
PEG Factor0.70 
EPS Growth Rate111.36%
Dividends PS Growth Rate-%
Net Debt11.21m
Gross Gearing143.68%
Quick Assets1.29m
Net Working Capital-9.45m
Intangibles / Fixed Assets77.34%
Turnover PS1.58p
Pre-Tax Profit PS-0.01p
Retained Profit PS0.05p
Cash PS0.27p
Net Cash PS-3.67p
Net Tangible Asset Value PS *-2.87p
Net Asset Value PS-1.24p
Spread0.60 (14.29%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Proteome Sciences Balance Sheet

LSE:PRM:Liabilities+EQLSE:PRM:Assets

Share Price Performance

Sample Period †HighLow
1 week4.503.82
4 weeks4.503.36
12 weeks5.003.10
1 year7.002.35

Share Price Chart (5 years)

Proteome Sciences Historic Returns

Period †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week4.30-0.40-9.303.820.244.21
4 weeks3.370.5315.733.360.214.03
12 weeks4.48-0.58-12.953.100.293.95
26 weeks3.320.5817.473.100.584.21
1 year2.521.3854.762.350.503.94
3 years3.150.7523.812.220.333.63
5 years17.50-13.60-77.712.220.365.58
† periods calculated are whole weeks rather than calendar months

Proteome Sciences Key Management Ratios

Proteome Sciences Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio4,199.37 
PE Ratio78.00 
Tobin's Q Ratio 1.49 
Tobin's Q Ratio (excl. intangibles)3.61 
Dividend Yield-%
Market-to-Book Ratio-3.15 
Price-to-Pre-Tax Profit PS-319.20 
Price-to-Retained Profit PS77.12 
Price-to-Cash Flow PS574.57 
Price-to-Sales PS2.47 
Price-to-Net Tangible Asset Value PS-1.36 
Price-to-Cash PS14.38 
Net Working Capital PS-3.21 
Price Pct to Working Capital PS-1.22%
Earnings Yield1.28%
Average PE59.00 
Years in average1 
PE to PE average132.20%

Proteome Sciences Financial Ratios

(Leverage Ratios)
Debt Ratio-12.40%
Debt-to-Equity Ratio-0.11 
Debt-to-Equity Ratio (excl. Intgbl)-0.05 
Debt-to-Equity Market Value0.04 
Net Gearing134.12%
Net Gearing (excl. Intangibles)314.82%
Gross Gearing143.68%
Gross Gearing (excl. Intangibles)337.25%
Gearing Under 1 Year138.86%
Gearing Under 1 Year (excl. Intgbl)325.94%
Assets/Equity-2.29 
Cash/Equity-21.88 
(Liquidity Ratios)
Net Working Capital to Total Assets-113.07%
Current Ratio0.19 
Quick Ratio (Acid Test)0.11 
Liquidity Ratio0.07 
Cash & Equiv/Current Assets37.06%
(Solvency Ratios)
Enterprise Value11.10m
CFO/Sales0.00 
CFO/Attributable Profit0.13 
CFO/Assets0.00 
CFO/Debt0.00 
Total Debt/Equity Market Value1.05 
Total Debt/Sales2.58 
Total Debt/Pre-Tax Profit-333.69 
Total Debt12.01m
Total Debt/Net Current Assets-1.27%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs9 
Beta (60-Mnth)Beta (36-Mnth)
-0.0088-0.0002

Proteome Sciences Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-%
Return On Assets (ROA)1.94%
Net Profit Margin3.20%
Assets Turnover0.61 
Return On Equity (ROE)-%
Return On Investment (ROI)-4.43%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues3.20%
(Asset Utilisation Multiples)
Shareholders Equity Turnover-1.25 
Fixed Assets Turnover0.89 
Current Assets Turnover1.90 
Net Working Capital Turnover 
Inventory Turnover4.61 
(Other Operating Ratios)
Total Assets-to-Sales1.65 
Debtors-to-Sales12.18%
Debt Collection Period44.45Days

Proteome Sciences Dividends

Sorry No Data Available

Proteome Sciences Fundamentals
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
turnover2.77100.00%3.38100.00%3.41100.00%4.66100.00%m
pre tax profit-2.94-106.09%-2.05-60.74%-1.66-48.67%-0.04-0.77%m
attributable profit-2.28-82.19%-2.50-73.88%-1.31-38.52%0.153.20%m
retained profit-2.28-82.19%-2.50-73.88%-1.31-38.52%0.153.20%m
eps - basic (p)-0.96 -0.85 -0.44 0.05 
eps - diluted (p)-0.96 -0.85 -0.44 0.05 
dividends per share- - - - 

Proteome Sciences Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
LSE:PRM:Liabilities+EQLSE:PRM:AssetsLSE:PRM:Liabilities+EQLSE:PRM:AssetsLSE:PRM:Liabilities+EQLSE:PRM:AssetsLSE:PRM:Liabilities+EQLSE:PRM:Assets
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
ASSETS
fixed assets fixed assets0.596.10%0.283.76%0.060.80%0.080.90%m
intangibles intangibles4.2243.48%4.2256.41%4.2260.03%4.8057.40%m
fixed investments fixed investments--%--%--%1.3315.92%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.606.19%0.9512.65%1.1516.32%0.8710.42%m
debtors debtors1.4114.49%1.1215.03%0.659.22%0.495.81%m
cash & securities cash & securities2.8829.73%0.9112.14%0.9613.63%0.809.56%m
TOTAL9.70100%7.48100%7.03100%8.36100%m
LIABILITIES
creditors - short creditors - short9.3696.52%9.67129.36%10.50149.45%11.61138.86%m
creditors - long creditors - long0.535.43%0.364.85%0.344.88%0.404.82%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL9.89101.95%10.04134.21%10.85154.33%12.01143.68%m
EQUITY
ord cap, reserves ord cap, reserves-0.19-1.95%-2.56-34.21%-3.82-54.33%-3.65-43.68%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL-0.19-1.95%-2.56-34.21%-3.82-54.33%-3.65-43.68%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Proteome Sciences Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF-1.99-1.70-0.500.02m
Pre-Financing CF-2.03-1.72-0.51-0.04m
Retained CF0.88-1.920.03-0.10m

Proteome Sciences Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MME)Broker/DealerCANAHOARGB21001
Liberum Capital LimitedMarket Maker(MME)Broker/DealerLIBCLCAPGB21
Morgan Stanley Securities LtdMarket Maker(MME)Broker/DealerMOSTMSSEGB21
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
LSE
PRM
Proteome S..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201020 21:10:03